Biotech
Automata has raised US$45m in a series C round to accelerate its lab automation platform for life sciences. The London-based company is building fully integrated, AI-ready platforms that combine modular robotics, orchestration software and unified data infrastructure to turn physical labs into programmable systems. The company said the funding will be used to scale customer [...]
Corxel has raised US$287m in a series D to fund phase 2 studies of its oral GLP-1 receptor agonist for obesity and support planned phase 3 trials. GLP-1 receptor agonists are medicines that mimic a natural hormone to help control blood sugar and reduce appetite, and have become a major focus in the weight-loss market. [...]
ErVimmune has announced a first closing of a €17m Series A to develop cancer vaccines for ‘cold tumours’ that often fail to respond to immunotherapies. The Lyon-based biotech is developing therapeutic vaccines and cell therapies for cold tumours, a term used for cancers that tend to evade immune-based treatments. The funding will support clinical development [...]
Kinaset Therapeutics has raised US$103m in a Series B to move forward frevecitinib, an inhaled asthma therapy for people not controlled by standard inhalers. The Boston-based firm is developing an inhaled treatment for serious respiratory diseases. The company will use the proceeds to advance frevecitinib, an inhaled dry powder being developed for people whose asthma [...]
QV Bioelectronics has secured £4.5m in investment and grant funding to develop what it calls a world-first glioblastoma implant. Cheshire-based medtech QV Bioelectronics said the funding will support an implantable device intended to improve outcomes for patients with glioblastoma. Glioblastoma, or GBM, is an aggressive brain tumour. Cancer Research UK says it accounted for about [...]
Gut health solutions company Bactolife has successfully raised over €30 million in its Series B investment round. The funding will enable the company to commercialise its innovative Binding Proteins, a new food, feed and dietary supplement ingredient, and execute its human study programme, aimed at transforming human and animal health for proactive health management. This [...]
A new nasal spray whooping cough vaccine could offer better protection and curb spread, scientists say. The vaccine, known as BPZE1, aims to stop the bacteria living in the nose and throat (blocking colonisation). Current vaccines do not give lifelong protection or prevent people carrying or transmitting it. Eleven babies died among about [...]
Amorphical, developer of nano-amorphous mineral-based pharmacologic agents for health conditions, today announced that the first patient has been enrolled in its Phase 2 clinical trial evaluating the company’s investigational nano-amorphous mineral-based therapy in patients with Stage IV pancreatic cancer. The study, approved by the Helsinki Committee of Shaare Zedek Medical Center and the Israel Ministry [...]
A new TB treatment called sorfequiline has shown stronger action against the bacteria than existing drugs in early-stage trial results. The antibiotic demonstrated what researchers describe as enhanced effectiveness against TB bacteria with a comparable safety profile to current treatments. The findings could lead to shorter treatment times and improved cure rates for a disease [...]
By Sergey Jakimov and Artem Trotsyuk, managing and operating partners, LongeVC Artificial intelligence is rapidly rewriting medicine – from clinics to labs – and scientists, startups, regulators, and investors are shaping that shift together. The global healthcare AI market is projected to soar from just over $1 billion in 2016 to more than $28 billion [...]
